Global approvals ROIS is FDA, EMA, ANVISA, PMDA, KFDA approved and serves more than 80 countries, indicating strong regulatory credibility and potential for multi-region CDMO partnerships and expansions.

aseptic capacity With 12 injectable filling lines (PFS and Vials) including Rabs and Isolator, ROIS offers high-volume aseptic fill-finish capabilities ideal for vaccines, biologics, and lyophilized products seeking scalable manufacturing.

recent leadership Recent appointment of a Chief Commercial Officer and ongoing asset investments signal a strategic push in commercial growth and capability expansion, creating opportunities for new contract manufacturing deals and long-term collaborations.

plant expansion Acquisition and investment in a pharmaceutical manufacturing plant in Phoenix, Arizona via ROIS Phoenix demonstrates geographic diversification and potential for onshore manufacturing partnerships, faster regulatory timelines, and regional supply resilience.

tech & integration Adoption of Salesforce, SAP, Microsoft 365 and other digital tools supports integrated operations and customer relationship management, enabling scalable collaboration with pharma sponsors and streamlined data exchange for audits and serialization.